Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Noble

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2024
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's diseaseKelsey R Sewell, James D Doecke, Chengjie Xiong, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A proteogenomic tool uncovers protein markers for human microglial statesVerena Haage, Alex R Bautista, John Tuddenham, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2024
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's diseaseKelsey R Sewell, James D Doecke, Chengjie Xiong, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A proteogenomic tool uncovers protein markers for human microglial statesVerena Haage, Alex R Bautista, John Tuddenham, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 7